Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
60%
Diabetes
49%
Insulin
41%
Type 2 Diabetes Mellitus (T2DM)
38%
Glucose Transporter 1 (GLUT1)
32%
Children with Type 1 Diabetes
30%
Hypoglycemia
30%
Glucose Transporter 4 (GLUT4)
25%
Hemoglobin A1c (HbA1c)
25%
Metformin
22%
Diabetes Complications
21%
Diabetes Control
20%
Glycemic Control
19%
Diabetes Prevention Program
19%
Sheep
18%
Glucagon
18%
Insulin Resistance
17%
Young children
17%
Severe Hypoglycemia
16%
Wolfram Syndrome
16%
Treatment Options
15%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
15%
Transgenic Mice
14%
Developmental Programming
14%
HIV Protease Inhibitors
14%
Risk Factors
13%
Diabetes Epidemiology
13%
Hyperglycemia
13%
Catenin
13%
Diabetes Intervention
13%
Glucose Transport
12%
Insulin Sensitivity
12%
Protease Inhibitors
11%
Adolescents with Type 1 Diabetes
11%
Retinopathy
11%
Overexpressing
10%
Intensive Care Medicine
10%
Metabolic Control
10%
Youth Studies
10%
Insulin Independence
10%
Blood Glucose
10%
Diabetic Ketoacidosis
10%
Cystic Fibrosis
9%
X-linked Hypophosphatemia
9%
Diabetes Duration
9%
Plasma Glucose
9%
Diabetic
9%
Liver
9%
Treatment Group
9%
Family Systems Therapy
8%
Skeletal muscle
8%
Older Adults
8%
Cell Function
8%
Parental Diabetes
8%
Diabetes Management
8%
Early-onset Type 2 Diabetes
8%
Program Outcomes
8%
Epinephrine
8%
High-fat Diet
7%
Insulin Secretion
7%
Diabetic Retinopathy
7%
Pediatric
7%
Burosumab
7%
Brain Development
7%
Insulin-dependent Diabetes
7%
Conventional Therapy
7%
Placebo
6%
Insulin Therapy
6%
Non-diabetic
6%
Glucose Level
6%
Glucose Homeostasis
6%
Lyase
6%
Clinical Trials
6%
Diabetic children
6%
Hypertension
6%
Nocturnal Hypoglycemia
6%
Facilitative Glucose Transporter
6%
Obesity
6%
Diabetic Patients
6%
Testosterone
6%
Cardiovascular Disease
6%
Hyperinsulinemia
6%
Puberty
6%
Inflammation
6%
Endoplasmic Reticulum Stress (ER stress)
6%
Lipids
6%
Bioavailable Testosterone
5%
Syndromic Diabetes
5%
Non-alcoholic Fatty Liver Disease (NAFLD)
5%
Oral Glucose Tolerance Test
5%
Liver Regeneration
5%
Control Subjects
5%
Hypophosphatasia
5%
Overexpression
5%
Insulin Requirement
5%
Conscious Dogs
5%
Randomized Controlled Trial
5%
Pancreas
5%
Bisphenol A
5%
Medicine and Dentistry
Diabetes
58%
Insulin Dependent Diabetes Mellitus
56%
Maturity Onset Diabetes of the Young
36%
Adolescence
33%
Hypoglycemia
21%
Diabetes Mellitus
19%
Pediatrics
19%
Glycon
17%
Diabetes Prevention
16%
Offspring
16%
Hemoglobin A1c
15%
Diabetes Control and Complications Trial
15%
Diseases
15%
Insulin Resistance
14%
Glucose Uptake
14%
X Linked Hypophosphatemic Rickets
13%
Diabetes in Adolescents
12%
Epidemiology of Diabetes
12%
Retinopathy
12%
Cardiovascular System
12%
Glycemic Control
11%
Intensive Care
11%
Transgenic Mouse
10%
Glucose Transporter 4
10%
Wolfram Syndrome
9%
Body Mass Index
9%
Glucose Transporter
9%
Glucose Transporter 1
8%
Human Immunodeficiency Virus Proteinase Inhibitor
8%
Skeletal Muscle
8%
Cardiovascular Disease
8%
Diabetic Retinopathy
8%
Hyperinsulinemia
8%
Insulin Release
8%
Cystic Fibrosis
7%
Burosumab
7%
Vitamin D
7%
Insulin Sensitivity
6%
Diabetic Ketoacidosis
6%
Hyperglycemia
6%
Adverse Event
6%
Lifestyle Intervention
6%
Hyperandrogenism
6%
Biological Marker
6%
In Vitro
6%
Hypophosphatasia
6%
Endoplasmic Reticulum Stress
5%
Proteinase Inhibitor
5%
Impaired Glucose Tolerance
5%
Rickets
5%
Alkaline Phosphatase
5%
Prevalence
5%
C-Peptide
5%
Bisphenol A
5%
Clinical Trial
5%
Disease
5%
Pregnancy
5%
Nonalcoholic Fatty Liver
5%
Blood Glucose
5%
Catenin
5%
Intrauterine Growth Retardation
5%
Treatment Group
5%
Adverse Effect
5%
Glycemic
5%